Pneumococcal conjugate vaccine (PCV) 2024

A contract for a vaccine to protect against invasive Pneumococcal disease, to be used as part of the national childhood immunisation programme. Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months. Value - The value has been withheld so as not to prejudice the legitimate commercial interest of the supplier.